Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Genmab A/S | GMAB | 4.05M | $111.12M |
Seaport Therapeutics, Inc. Common Stock | SPTX | 3.56M | $77.43M |
Vera Therapeutics, Inc. | VERA | 2.79M | $119.89M |
BioAge Labs Inc. | BIOA | 2.29M | $56.22M |
Rapport Therapeutics, Inc. Common Stock | RAPP | 1.9M | $79.36M |
Ultragenyx Pharmaceutical Inc. | RARE | 1.72M | $57.35M |
ArriVent BioPharma, Inc. | AVBP | 1.7M | $58.95M |
Dyne Therapeutics, Inc. | DYN | 1.66M | $36.83M |
Natera, Inc. | NTRA | 1.55M | $420.82M |
Supernus Pharmaceuticals, Inc. | SUPN | 1.04M | $48.2M |
Cogent Biosciences, Inc. | COGT | 1.04M | $40.06M |
Arcus Biosciences, Inc. | RCUS | 945.69K | $29.16M |
IDEAYA Biosciences, Inc. | IDYA | 925.12K | $34.48M |
Pharvaris N.V. | PHVS | 881.3K | $30.48M |
Bristol-Myers Squibb Company | BMY | 876.97K | $50.53M |
Design Therapeutics, Inc. | DSGN | 865.13K | $12.52M |
First Tracks Biotherapeutics Inc | TRAX | 565.2K | $11.37M |
Nurix Therapeutics, Inc. | NRIX | 524.1K | $12.71M |
AnaptysBio, Inc. | ANAB | 493.54K | $33.31M |
Nektar Therapeutics | NKTR | 471.76K | $32.93M |